Ukko
On a mission to solve food allergies and sensitivities
Israel
56 employees
Series B
Total: $47.70M
Biotechnology, Food and Beverage +1
General Information
Israel
BounceWatch is an independent company data service, not affiliated with Ukko. To contact Ukko, visit ukko.us.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Ukko compare?
A PDF of Ukko and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Ukko soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Ukko on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Israel Market
Biotechnology
About Ukko
Business keywords: Biotech, Immunology, Computational biology, Plant science, Food allergies, Therapeutics, Allergy therapy, Molecular structure, Proteins, Immune response, Clinical validation, Biological mechanisms
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $40.00M | 8 |
|
27 Jan 2021 |
| Venture Round | $7.70M | 1 |
|
24 Jul 2017 |
Ukko Alternatives & Competitors
View All Alternatives
A game changer in human genome engineering to foster health and longevity for EVERYONE.
Pioneering Therapeutics Targeting Cellular Stress Pathways
Revolutionizing Cell Therapy with Protein Design
FAQ About Ukko
Source: BounceWatch company record for Ukko, https://www.bouncewatch.com/company/ukko, updated 30 December 2024. When citing, please name BounceWatch and link this page.
